Positive PD-L1 expression is predictive for patients with advanced EGFR wild-type non-small cell lung cancer treated with gemcitabine and cisplatin

This retrospective study aimed to investigate the association between programmed death ligand-1 (PD-L1) expression and the clinicopathological characteristics of patients with advanced epidermal growth factor receptor (EGFR) wild-type non-small cell lung cancer (NSCLC). The predictive role and cut-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yajuan, Jiang, Junguang, Zhang, Mingzhi, Qin, Yanru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539442/
https://www.ncbi.nlm.nih.gov/pubmed/31289485
http://dx.doi.org/10.3892/ol.2019.10302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539442/
https://www.ncbi.nlm.nih.gov/pubmed/31289485
http://dx.doi.org/10.3892/ol.2019.10302

Ejemplares similares